These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis. Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265 [No Abstract] [Full Text] [Related]
6. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation. Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836 [TBL] [Abstract][Full Text] [Related]
7. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin. Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795 [TBL] [Abstract][Full Text] [Related]
9. Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain. Lorger M; Krueger JS; O'Neal M; Staflin K; Felding-Habermann B Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10666-71. PubMed ID: 19541645 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Cai W; Chen X Anticancer Agents Med Chem; 2006 Sep; 6(5):407-28. PubMed ID: 17017851 [TBL] [Abstract][Full Text] [Related]
11. Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells. Shen J; Zhu Y; Zhang S; Lyu S; Lyu C; Feng Z; Hoyle DL; Wang ZZ; Cheng T Cell Prolif; 2021 Apr; 54(4):e13012. PubMed ID: 33656760 [TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone as a regulator of tumor induced angiogenesis. Pinto M; Soares P; Ribatti D Cancer Lett; 2011 Feb; 301(2):119-26. PubMed ID: 21183275 [TBL] [Abstract][Full Text] [Related]
13. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo. Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116 [TBL] [Abstract][Full Text] [Related]
14. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3. Komiya E; Sato H; Watanabe N; Ise M; Higashi S; Miyagi Y; Miyazaki K Cancer Med; 2014 Jun; 3(3):537-49. PubMed ID: 24737780 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of nongenomic actions of thyroid hormone. Davis PJ; Leonard JL; Davis FB Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645 [TBL] [Abstract][Full Text] [Related]
16. Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior. Davis PJ; Mousa SA; Cody V; Tang HY; Lin HY Horm Cancer; 2013 Dec; 4(6):335-42. PubMed ID: 23943159 [TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway. Liu X; Zheng N; Shi YN; Yuan J; Li L J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656 [TBL] [Abstract][Full Text] [Related]
18. TDCPP mimics thyroid hormones associated with the activation of integrin α Li J; Liu H; Li N; Wang J; Song L Chemosphere; 2020 Oct; 256():127066. PubMed ID: 32434091 [TBL] [Abstract][Full Text] [Related]
19. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3. Lin HY; Mousa SA; Davis PJ Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817 [TBL] [Abstract][Full Text] [Related]
20. Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins. Huang H; Huang Q; Wang F; Milner R; Li L J Neuroinflammation; 2016 Sep; 13(1):227. PubMed ID: 27586239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]